Monocyclic compounds useful as GPR120 modulators
US12116362B2 · kind B2 · utility
0Cited by
11References
21Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 3, 2022 |
| Grant date | Oct 15, 2024 |
| Priority date | — |
| Expiry date | Oct 3, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D471/04
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Provided herein are compounds, compositions including them, and methods of modulating GPR120 activity and treating diseases mediated by GPR120 by administering such compounds and compositions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.